In an effort to produce processed, soluble Western equine encephalitis virus (WEEV) glycoproteins for subunit therapeutic vaccine studies, we isolated twelve recombinant baculoviruses designed to express four different WEEV glycoprotein constructs under the transcriptional control of three temporally distinct baculovirus promoters. The WEEV glycoprotein constructs encoded full-length E1, the E1 ectodomain, an E26KE1 polyprotein precursor, and an artificial, secretable E2E1 chimera. The three different promoters induced gene expression during the immediate early (ie1), late (p6.9), and very late (polh) phases of baculovirus infection. Protein expression studies showed that the nature of the WEEV construct and the timing of expression both influenced the quantity and quality of recombinant glycoprotein produced. The full-length E1 product was insoluble, irrespective of the timing of expression. Each of the other three constructs yielded soluble products and, in these cases, the timing of expression was important, as higher protein processing efficiencies were generally obtained at earlier times of infection. However, immediate early expression did not yield detectable levels of every WEEV product, and expression during the late (...Continue Reading
Expression and characterization of poliovirus proteins 3BVPg, 3Cpro, and 3Dpol in recombinant baculovirus-infected Spodoptera frugiperda cells
Biochemical and biological characteristics of epitopes on the E1 glycoprotein of western equine encephalitis virus
Glycosylation and secretion of human tissue plasminogen activator in recombinant baculovirus-infected insect cells.
Baculovirus polyhedrin promoter-directed expression of rubella virus envelope glycoproteins, E1 and E2, in Spodoptera frugiperda cells
A rapid, sensitive method for detection of alkaline phosphatase-conjugated anti-antibody on Western blots
Influence of promoter and signal peptide on the expression and secretion of recombinant porcine LH extracellular domain in baculovirus/lepidopteran cells or the caterpillar system
The production of an active protein kinase C-delta in insect cells is greatly enhanced by the use of the basic protein promoter
Temporal nature of the promoter and not relative strength determines the expression of an extensively processed protein in a baculovirus system
Immediate-early baculovirus vectors for foreign gene expression in transformed or infected insect cells
Expression, processing, and immunogenicity of the structural proteins of Venezuelan equine encephalitis virus from recombinant baculovirus vectors
Viruses of the Bunya- and Togaviridae families: potential as bioterrorism agents and means of control
Molecular cloning and functional characterization of beta-N-acetylglucosaminidase genes from Sf9 cells
Ross River virus envelope glycans contribute to type I interferon production in myeloid dendritic cells
Identification of Western equine encephalitis virus structural proteins that confer protection after DNA vaccination.
Expression and structural properties of a chimeric protein based on the ectodomains of E1 and E2 hepatitis C virus envelope glycoproteins
Utility of temporally distinct baculovirus promoters for constitutive and baculovirus-inducible transgene expression in transformed insect cells
Bioluminescent imaging and histopathologic characterization of WEEV neuroinvasion in outbred CD-1 mice
A novel baculovirus vector for the production of nonfucosylated recombinant glycoproteins in insect cells
Production of pseudorabies virus recombinant glycoprotein B and its use in an agar gel immunodiffusion (AGID) test for detection of antibodies with sensitivity and specificity equal to the virus neutralization assay
Innovative use of a bacterial enzyme involved in sialic acid degradation to initiate sialic acid biosynthesis in glycoengineered insect cells.
Characterization of an Sf-rhabdovirus-negative Spodoptera frugiperda cell line as an alternative host for recombinant protein production in the baculovirus-insect cell system
Use of baculovirus expression system for generation of virus-like particles: successes and challenges
A new insect cell glycoengineering approach provides baculovirus-inducible glycogene expression and increases human-type glycosylation efficiency
Engineering β1,4-galactosyltransferase I to reduce secretion and enhance N-glycan elongation in insect cells
Venezuelan and western equine encephalitis virus E1 liposome antigen nucleic acid complexes protect mice from lethal challenge with multiple alphaviruses
Combined alphavirus replicon particle vaccine induces durable and cross-protective immune responses against equine encephalitis viruses
Liposome-antigen-nucleic acid complexes protect mice from lethal challenge with western and eastern equine encephalitis viruses
Isolation and characterization of a novel strain (YH01) of Micropterus salmoides rhabdovirus and expression of its glycoprotein by the baculovirus expression system
CREs: Gene & Cell Therapy
Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.